Alegado, Jeicel C.
HRN: 23-12-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/31/2023
06/06/2023
IV
55mg
Q8Hrs
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes